T Cell-Depleted Stem Cell Transplantation for Adults with High-Risk Acute Lymphoblastic Leukemia: Long-Term Survival for Patients in First Complete Remission with a Decreased Risk of Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 2, 2013, Pages 208-213

  Goldberg, Jenna D ^a   Linker, Alex ^a   Kuk, Deborah ^a   Ratan, Ravin ^a   Jurcic, Joseph ^a   Barker, Juliet N ^a   Castro Malaspina, Hugo ^a   Giralt, Sergio ^a   Hsu, Katharine ^a   Jakubowski, Ann A ^a   Jenq, Robert ^a   Koehne, Guenther ^a   Papadopoulos, Esperanza B ^a   van den Brink, Marcel R M ^a   Young, James W ^a   Boulad, Farid ^a   Kernan, Nancy A ^a   O'Reilly, Richard J ^a   Prockop, Susan E ^a   Yahalom, Joachim ^a   Heller, Glenn ^a   Perales, Miguel Angel ^a   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acute lymphoblastic leukemia; Allogeneic transplantation; T cell depletion

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; METHYLPREDNISOLONE; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; DONOR LYMPHOCYTE INFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; SURVIVAL RATE; T CELL DEPLETION;

ADOLESCENT; ADULT; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84872508758     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.09.003     Document Type: Article

References (28)

1. Pui C.H., Evans W.E. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006, 354:166-178.
2. Fielding A.K., Richards S.M., Chopra R., et al. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL): an MRC UKALL12/ECOG 2993 study. Blood 2007, 109:944-950.
3. Tavernier E., Boiron J.M., Huguet F., et al. Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial. Leukemia 2007, 21:1907-1914.
4. Camera A., Annino L., Chiurazzi F., et al. GIMEMA ALL-Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia. Haematologica 2004, 89:145-153.
5. Sebban C., Lepage E., Vernant J.P., et al. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. J Clin Oncol 1994, 12:2580-2587.
6. Thiebaut A., Vernant J.P., Degos L., et al. Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation: a follow-up report of the French protocol LALA 87. Hematol Oncol Clin North Am 2000, 14:1353-1366.
7. Cornelissen J.J., Carston M., Kollman C., et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. Blood 2001, 97:1572-1577.
8. Thomas X., Boiron J.M., Huguet F., et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004, 22:4075-4086.
9. Hunault M., Harousseau J.L., Delain M., et al. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood 2004, 104:3028-3037.
10. Fielding A.K., Rowe J.M., Richards S.M., et al. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. Blood 2009, 113:4489-4496.
11. Labar B., Suciu S., Zittoun R., et al. Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients ≤50 years old in first complete remission: results of the EORTC ALL-3 trial. Haematologica 2004, 89:809-817.
12. Ribera J.M., Oriol A., Bethencourt C., et al. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia: results of the PETHEMA ALL-93 trial. Haematologica 2005, 90:1346-1356.
13. Yanada M., Matsuo K., Suzuki T., et al. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis. Cancer 2006, 106:2657-2663.
14. Goldstone A.H., Richards S.M., Lazarus H.M., et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008, 111:1827-1833.
15. Cornelissen J.J., van der Holt B., Verhoef G.E., et al. Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood 2009, 113:1375-1382.
16. Papadopoulos E.B., Carabasi M.H., Castro-Malaspina H., et al. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood 1998, 91:1083-1090.
17. Jakubowski A.A., Small T.N., Young J.W., et al. T cell-depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood 2007, 110:4552-4559.
18. Castro-Malaspina H., Jabubowski A.A., Papadopoulos E.B., et al. Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings. Biol Blood Marrow Transplant 2008, 14:458-468.
19. Perales M.A., Jenq R., Goldberg J.D., et al. Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell-depleted allogeneic hematopoietic SCT. Bone Marrow Transplant 2010, 45:1408-1416.
20. Kernan N.A., Flomenberg N., Collins N.H., et al. Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay. Transplantation 1985, 40:317-322.
21. Kernan N.A., Bordignon C., Heller G., et al. Graft failure after T-cell-depleted human leukocyte antigen-identical marrow transplants for leukemia, I: analysis of risk factors and results of secondary transplants. Blood 1989, 74:2227-2236.
22. Rowlings P.A., Przepiorka D., Klein J.P., et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997, 97:855-864.
23. Sullivan K.M. Chronic graft-versus-host disease. Cancer Treat Res 1990, 50:79-98.
24. Copelan E., Casper J.T., Carter S.L., et al. A scheme for defining cause of death and its application in the T cell depletion trial. Biol Blood Marrow Transplant 2007, 13:1469-1476.
25. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
26. Moorman A.V., Harrison C.J., Buck G.A., et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 2007, 109:3189-3197.
27. Weinstock D.M., Conlon M., Iovino C., et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007, 13:615-621.
28. Devine S.M., Carter S., Soiffer R.J., et al. Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303. Biol Blood Marrow Transplant 2011, 17:1343-1351.